Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT01419132
Eligibility Criteria:
Inclusion Criteria:
* signs/symptoms of heart failure;
* New York Heart Association (NYHA) functional Class III or IV on admission due to an exacerbation of symptoms with at least 1 class deterioration;
* evidence of systolic dysfunction on echocardiographic examination on admission (EF\<45%);
* BNP levels on admission \> 100pg/mL
Exclusion Criteria:
* NYHA class \< III on admission or without a NYHA class improvement on discharge;
* acute coronary syndrome,
* pulmonary thromboembolism,
* cardiac tamponade,
* pericarditis,
* renal insufficiency (serum creatinine \<2,5 mg/dL, BUN \<60 mg/dL) or those on dialysis;
* chronic liver disease,
* pleuro-pneumonia,
* blood and autoimmune diseases,
* concomitant other important co-morbidity,
* cerebral vascular disease,
* dementia,
* cancer,
* uncompensated diabetes,
* took non-steroid anti-inflammatory drugs (NSAID)
* declining to provide informed consent,
* patients requiring pacemaker implantation and those with issues of excessive alcohol consumption
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT01419132
Study Brief:
Protocol Section:
NCT01419132